Yale’s Antibody-RNA Therapy: Tackling Treatment Resistant Cancers Recent advances at Yale are reshaping the fight against some of the toughest cancers. Researchers have engineered a unique antibody-RNA therapy that offers renewed hope for patients where traditional ... antibody-RNA cancer therapy clinical trials immunotherapy precision medicine resistant tumors Yale research
Unveiling Hidden Cell Subtypes to Transform Cancer Research CellLENS is a groundbreaking artificial intelligence tool developed by a multidisciplinary team led by MIT designed to precisely identify which immune cells are fighting, helping, or hindering tumors,... artificial intelligence biomarkers cancer research cell subtypes deep learning immunotherapy precision medicine